CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

113 hedge funds and large institutions have $169M invested in Cymabay Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 37 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
–
Holders Change %
0%
% of All Funds
1.98%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
18
Increased
23
Reduced
37
Closed
17
Calls
$1.41M
Puts
$2.72M
Net Calls
-$1.31M
Net Calls Change
+$44K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$4.86M
2
CC
2
Commodore Capital
New York
$15.2M
3
GCP
3
GSA Capital Partners
United Kingdom
$964K
4
OM
4
Opaleye Management
Massachusetts
$420K
5
Franklin Resources
5
Franklin Resources
California
$417K

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
Norges Bank
2
Norges Bank
Norway
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$1.4M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$2.84M
5
Charles Schwab
5
Charles Schwab
California
$635K
Name Holding Trade Value Shares
Change 		Shares
Change %
FI
26
Fosun International
China
$962K – – –
Invesco
27
Invesco
Georgia
$944K +$74.8K +20,482 +9%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$911K +$32K +8,784 +4%
Massachusetts Financial Services
29
Massachusetts Financial Services
Massachusetts
$868K -$11.4K -3,121 -1%
PPA
30
Parametric Portfolio Associates
Washington
$864K +$79.6K +21,817 +10%
Morgan Stanley
31
Morgan Stanley
New York
$656K -$1.19M -327,215 -65%
Charles Schwab
32
Charles Schwab
California
$635K -$1.3M -357,375 -67%
Deutsche Bank
33
Deutsche Bank
Germany
$610K -$878K -240,493 -59%
CM
34
CM Management
Florida
$548K – – –
Goldman Sachs
35
Goldman Sachs
New York
$522K +$2.19K +601 +0.4%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$502K – – –
A
37
Abingworth
United Kingdom
$478K – – –
Rockefeller Capital Management
38
Rockefeller Capital Management
New York
$452K +$91.1K +25,000 +25%
OM
39
Opaleye Management
Massachusetts
$420K +$420K +115,015 New
Franklin Resources
40
Franklin Resources
California
$417K +$337K +92,215 +419%
CAM
41
ClariVest Asset Management
California
$415K -$2.56K -700 -0.6%
Citadel Advisors
42
Citadel Advisors
Florida
$404K -$883K -241,668 -69%
AllianceBernstein
43
AllianceBernstein
Tennessee
$388K – – –
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$388K +$7.62K +2,086 +2%
Bank of America
45
Bank of America
North Carolina
$384K +$52.7K +14,440 +16%
RJA
46
Raymond James & Associates
Florida
$303K -$60.2K -16,507 -17%
CAC
47
Cowen and Company
New York
$262K +$260K +71,277 +13,628%
DCM
48
Dupont Capital Management
Delaware
$207K -$29.3K -8,007 -12%
HF
49
HRT Financial
New York
$189K +$189K +51,853 New
MMA
50
Miracle Mile Advisors
California
$183K +$91.5K +25,000 +100%
1
2
3 4 5